Stivarga 40 mg

Stivarga 40 mg is a prescription medication primarily used for treating certain types of advanced cancers, including colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma. It works by inhibiting multiple protein kinases involved in tumor growth and angiogenesis, helping to slow cancer progression. Administered orally, Stivarga requires careful medical supervision to manage dosage and monitor potential side effects. Its targeted mechanism offers an important treatment option for patients with limited alternatives.